A phase II trial of hepatic ablation of metastases to modulate and enhance immunotherapy response in non-small cell lung cancer (HAMMER-NSCLC). - McMillan, Matthew T.; Reyngold, Marsha; Crane, Christopher H.; O'Brien, Diana A. Roth; Williams, Vonetta M.; Zinovoy, Melissa; Cuaron, John J.; Gönen, Mithat; Kaiser, Adeel; Sopka, Dennis M.; Gomez, Daniel R.; Schoenfeld, Adam J.; et al. (BMC Cancer, 2025)